Latest news

Beyond DNA — Studying RNA to Understand Treatment Resistance and Prescribe Truly Personalized Cancer Therapies

January 25, 2021
Cancer scientists are going beyond DNA to study RNA and the transcriptome. A recent Omicure et al. article in the Journal of Clinical Colorectal Cancer highlights how RNA sequencing is revealing further characteristics of cancer than those known via DNA. This can potentially lead to additional therapeutic options, particularly once treatment resistance has set in.
READ MORE

RNA Molecular Profiling Bridges the Gap of DNA-Only Profiling in Precision Oncology

June 16, 2020
Advances in scientific research and technology have all contributed to a decrease in the cancer mortality rate across the world. Still, cancer remains an untamed beast that continues...
READ MORE

Tumor profiling: Shifting from DNA to RNA sequencing

March 2, 2020
Personalized biopsy-driven treatment based on DNA sequencing has been tested in various settings for over ten years. Unfortunately, the response rate is disappointing. A recent study shows that profiling RNA, instead of DNA, allows the more advanced cancer patients to benefit from personalized therapies, compared to the standard analysis of DNA alterations alone.
READ MORE

New Study into Benefits of RNA Tumor Profiling Provides Hope for More Effective Cancer Treatment

April 2, 2020
OmiCure is excited about the future of precision oncology treatment, thanks to a recent study conducted by the National Cancer Institute. While there is still a considerable amount of...
READ MORE